Nova Patents
AT342916T

SYNTHETIC HIV $i(GAG) GENES

Abstract

Relates to a HIV and modification and synthetic DNA of HIV and. The synthesizing codon component is a predetermined host cell preferably codon. The synthesizing method can be used as a vaccine polynucleotide, wherein the vaccine by the excitation of neutralizing and cell mediated the claims, wherein the effective is anti-HIV of infection.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

31 members in 22 offices

This recordMember, by publication datePriority claim12 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
3785497United States of AmericaP
9705040United KingdomA

Members31

Family members, oldest first
DocumentOfficeKind
GB9705040D0United KingdomD0
CA2280195A1CanadaA1
WO9834640A2World Intellectual Property Organization (WIPO)A2
AU6271198AAustraliaA
WO9834640A3World Intellectual Property Organization (WIPO)A3
ZA98969BSouth AfricaB
NO993810D0NorwayD0
NO993810LNorwayL
EP0969862A2European Patent Office (EPO)A2
EE9900343AEstoniaA
PL335050A1PolandA1
EA199900726A1Eurasian Patent Organization (EAPO)A1
CN1252075AChinaA
SK106699A3SlovakiaA3
HU0001347A2HungaryA2
HUP0001347A2HungaryA2
KR20000070865ARepublic of KoreaA
IL131131D0IsraelD0
JP2001512308AJapanA
AU743616B2AustraliaB2
US2003050468A1United States of AmericaA1
US6696291B2United States of AmericaB2
US2004180329A1United States of AmericaA1
EP0969862B1European Patent Office (EPO)B1
AT342916TThis recordAustriaT
ATE342916T1AustriaT1
DE69836206D1GermanyD1
PT969862EPortugalE
DK0969862T3DenmarkT3
ES2274566T3SpainT3
DE69836206T2GermanyT2